{"abstract":"The Drug Enforcement Administration proposes to remove [\\18\\F]FP-CIT (chemical names: [\\18\\F]N-[omega]-fluoropropyl-[beta]- CIT; fluorine-18-N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4- iodophenyl)tropane; [\\18\\F]fluoropropylcarbomethoxy nortropane) from the schedules of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. [\\18\\F]FP-CIT is currently a schedule II controlled substance because it can be derived from cocaine, a schedule II substance, via ecgonine, also a schedule II substance. This action would remove the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle [\\18\\F]FP-CIT.","action":"Notice of proposed rulemaking.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/11/04/2021-23852.html","cfr_references":[{"chapter":null,"citation_url":null,"part":1308,"title":21}],"citation":"86 FR 60785","comment_url":null,"comments_close_on":"2021-12-06","correction_of":null,"corrections":[],"dates":"Interested persons may file written comments on this proposal in accordance with 21 CFR 1308.43(g). Electronic comments must be submitted, and written comments must be postmarked, on or before December 6, 2021. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.","disposition_notes":null,"docket_ids":["Docket No. DEA-837"],"dockets":[{"supporting_documents":[{"title":"DEA837 8FA 18F  FP-CIT DOE-21-632","document_id":"DEA-2021-0025-0003"},{"title":"FINAL SIGNED - Fluoroseek Letter and review 16Apr2021","document_id":"DEA-2021-0025-0002"}],"agency_name":"DEA","documents":[{"comment_count":6,"comment_start_date":"2021-11-04","updated_at":"2023-02-28T12:39:44.204-05:00","comment_url":"https://www.regulations.gov/commenton/DEA-2021-0025-0001","allow_late_comments":null,"id":"DEA-2021-0025-0001","comment_end_date":"2021-12-07","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":2,"id":"DEA-2021-0025","title":"Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control"}],"document_number":"2021-23852","effective_on":null,"end_page":60790,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/11/04/2021-23852.xml","html_url":"https://www.federalregister.gov/documents/2021/11/04/2021-23852/schedules-of-controlled-substances-removal-of-18ffp-cit-from-control","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-23852?publication_date=2021-11-04","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-11-04/2021-23852/mods.xml","not_received_for_publication":null,"page_length":6,"page_views":{"count":793,"last_updated":"2026-04-04 12:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-11-04/pdf/2021-23852.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-23852.pdf?1635943522","publication_date":"2021-11-04","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/11/04/2021-23852.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"DEA837 8FA 18F  FP-CIT DOE-21-632","document_id":"DEA-2021-0025-0003"},{"title":"FINAL SIGNED - Fluoroseek Letter and review 16Apr2021","document_id":"DEA-2021-0025-0002"}],"comments_count":6,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2021-0025","supporting_documents_count":2,"docket_id":"DEA-2021-0025","document_id":"DEA-2021-0025-0001","regulation_id_number":null,"title":"Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control","checked_regulationsdotgov_at":"2023-02-28T17:39:43Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":60785,"subtype":null,"title":"Schedules of Controlled Substances: Removal of [18F]FP-CIT From Control","toc_doc":"Removal of [18F]FP-CIT from Control","toc_subject":"Schedules of Controlled Substances:\n","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":86}